Helsinn Wants On-Sale Bar Ruling Held For High Court Appeal
The Federal Circuit has given Teva Pharmaceuticals until Monday to reply to Helsinn Healthcare's last-ditch bid to keep Teva from launching a generic version of Helsinn's Aloxi anti-nausea drug while it...To view the full article, register now.
Already a subscriber? Click here to view full article